Laboratorios Farmacéuticos Rovi SA logo

Laboratorios Farmacéuticos Rovi SA (0ILL)

Market Open
7 Aug, 15:30
LSE LSE
58. 20
-0.35
-0.5978%
- Market Cap
- P/E Ratio
4.37% Div Yield
2,128 Volume
- Eps
58.55
Previous Close
Add Transaction
Day Range
58.15 59.05
Year Range
51.75 87.5
Want to track 0ILL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Laboratorios Farmacéuticos Rovi SA (0ILL) Statistics

Valuation metrics

Market Cap -
Enterprise value 2.96B
Trailing P/E (ttm) 16.12
Forward P/E -
PEG ratio -2.41
Price/Sales (ttm) 3.86
Price/Book (mrq) 4.26
Enterprise Value/Revenue 3.84
Enterprise Value/EBITDA 11.14

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 7.74K
Average volume (90 days) 19.33K

Price summary

52-Week low 51.75
52-Week high 87.5
Beta -
50-Day moving average 57.37
200-Day moving average 69.2

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.78
Trailing annual dividend yield 0.0133%
5-Year annual dividend yield -
Payout ratio 0.26
Dividend Date 15 Jul 2026
Ex-Dividend Date 13 Jul 2026
Last split factor -
Last split Date -

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.24%
Operating margin 0.22%

Operational effectiveness

Return on assets 0.16%
Return on equity 0.28%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 15.11
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 3.62
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 2.5
Total debt (mrq) -
Total Debt/Equity (mrq) 0.15
Current ratio (mrq) 2.05%
Book value per share (mrq) 14.02

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -